The minister mentioned the antiviral drug is now being produced throughout 57 crops within the nation in contrast to 20 services a month in the past.
Production of Remdesivir is being enhanced and within the few days, India has seen the manufacturing capability of the antiviral drug go up by thrice, Mandaviya mentioned.
देश में तेज़ गति से रेमडेसिवीर का उत्पादन बढ़ाया जा रहा है Iसिर्फ कुछ ही दिनों में भारत ने रेमडेसिवीर की उत्पादन… https://t.co/t96StZK21m
— Mansukh Mandaviya (@mansukhmandviya) 1620111894000
देश में #Remdesivir की बढ़ती मांग को देखते हुए भारत रेमडेसिविर का उत्पादन बढ़ा रहा है। कुछ दिन में ही लगभग 3 गुना… https://t.co/I04lq4X7EY
— Mansukh Mandaviya (@mansukhmandviya) 1620113628000
“Soon, we will be able to cater to increase in demand,” he added.
Demand for Remdesivir has gone up manifold within the nation amid a large spike in COVID infections.
The authorities has already waived customs responsibility on Remdesivir, its uncooked supplies and different elements used to make the antiviral drug so as to assist increase home availability and scale back the price of the injection.
On April 11, in view of increased demand for Remdesivir, the Centre banned the export of the injection and its APIs until the scenario improves.
Various drug corporations have additionally reduce the costs of Remdesivir injection following intervention of the federal government.
India’s whole tally of COVID instances has crossed the 2-crore mark with over 50 lakh infections being added in simply 15 days.
The tally rose to 2,02,82,833 with 3,57,229 new infections being reported in a day whereas the demise toll increased to 2,22,408 with 3,449 new fatalities, in accordance to the Union well being ministry knowledge up to date on Tuesday.